glp 1 gip 2ra GLP-1 & Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) Understand GLP-1/GIP Dual Agonist Tirzepatide
Description
This could dramatically change the existing GLP-1 market, which is dominated by injectables
It is FDA-approved, widely available, and produces roughly 30-50% more weight loss than semaglutide in clinical trials
The Lancet, 402(10401), 529-544.
Biomarker Context and Donation Eligibility Assessment Blood donation centers routinely assess hemoglobin, blood pressure, and overall cardiovascular stability
